Eam Investors, LLC X Biotech Inc. Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$8.89 - $24.94 $359,227 - $1.01 Million	-40,408 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$8.33 - $19.95 $189,091 - $452,865	-22,700 Reduced 35.97%	40,408 $754,000
Q3 2019 Nov 13, 2019	BUY	$6.86 - $10.46 $12,217 - $18,629	1,781 Added 2.9%	63,108 $660,000
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $202,870 - $327,089	-29,023 Reduced 32.12%	61,327 $465,000
Q1 2019 May 13, 2019	SELL	$5.05 - $11.62 $177,840 - $409,209	-35,216 Reduced 28.05%	90,350 $996,000
Q4 2018 Feb 13, 2019	BUY	$3.22 - $6.27 $404,322 - $787,298	125,566 New	125,566 $638,000

4.9M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $102M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.